Natera (NTRA) Competitors $150.93 -3.96 (-2.56%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NTRA vs. FMS, HIMS, GH, OPCH, RDNT, SHC, WGS, BTSG, PRVA, and CONShould you be buying Natera stock or one of its competitors? The main competitors of Natera include Fresenius Medical Care (FMS), Hims & Hers Health (HIMS), Guardant Health (GH), Option Care Health (OPCH), RadNet (RDNT), Sotera Health (SHC), GeneDx (WGS), BrightSpring Health Services (BTSG), Privia Health Group (PRVA), and Concentra Group Holdings Parent (CON). These companies are all part of the "healthcare" industry. Natera vs. Fresenius Medical Care Hims & Hers Health Guardant Health Option Care Health RadNet Sotera Health GeneDx BrightSpring Health Services Privia Health Group Concentra Group Holdings Parent Fresenius Medical Care (NYSE:FMS) and Natera (NASDAQ:NTRA) are both large-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, profitability, dividends, community ranking, risk, valuation, analyst recommendations, media sentiment and institutional ownership. Is FMS or NTRA more profitable? Fresenius Medical Care has a net margin of 3.43% compared to Natera's net margin of -14.01%. Fresenius Medical Care's return on equity of 6.04% beat Natera's return on equity.Company Net Margins Return on Equity Return on Assets Fresenius Medical Care3.43% 6.04% 2.69% Natera -14.01%-26.23%-14.27% Does the MarketBeat Community favor FMS or NTRA? Natera received 68 more outperform votes than Fresenius Medical Care when rated by MarketBeat users. Likewise, 68.96% of users gave Natera an outperform vote while only 54.72% of users gave Fresenius Medical Care an outperform vote. CompanyUnderperformOutperformFresenius Medical CareOutperform Votes42354.72% Underperform Votes35045.28% NateraOutperform Votes49168.96% Underperform Votes22131.04% Which has better earnings and valuation, FMS or NTRA? Fresenius Medical Care has higher revenue and earnings than Natera. Natera is trading at a lower price-to-earnings ratio than Fresenius Medical Care, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioFresenius Medical Care$19.34B0.77$540.07M$0.9925.46Natera$1.70B11.99-$434.80M-$1.53-98.33 Do institutionals & insiders have more ownership in FMS or NTRA? 8.4% of Fresenius Medical Care shares are held by institutional investors. Comparatively, 99.9% of Natera shares are held by institutional investors. 7.6% of Natera shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Does the media prefer FMS or NTRA? In the previous week, Natera had 21 more articles in the media than Fresenius Medical Care. MarketBeat recorded 27 mentions for Natera and 6 mentions for Fresenius Medical Care. Fresenius Medical Care's average media sentiment score of 1.41 beat Natera's score of 1.38 indicating that Fresenius Medical Care is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Fresenius Medical Care 5 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Natera 23 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more risk & volatility, FMS or NTRA? Fresenius Medical Care has a beta of 0.93, meaning that its share price is 7% less volatile than the S&P 500. Comparatively, Natera has a beta of 1.8, meaning that its share price is 80% more volatile than the S&P 500. Do analysts prefer FMS or NTRA? Fresenius Medical Care presently has a consensus price target of $25.30, indicating a potential upside of 0.36%. Natera has a consensus price target of $175.76, indicating a potential upside of 16.83%. Given Natera's stronger consensus rating and higher possible upside, analysts clearly believe Natera is more favorable than Fresenius Medical Care.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Fresenius Medical Care 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.33Natera 0 Sell rating(s) 0 Hold rating(s) 16 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryNatera beats Fresenius Medical Care on 10 of the 18 factors compared between the two stocks. Get Natera News Delivered to You Automatically Sign up to receive the latest news and ratings for NTRA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NTRA vs. The Competition Export to ExcelMetricNateraMedical laboratories IndustryMedical SectorNASDAQ ExchangeMarket Cap$20.34B$2.86B$5.53B$7.73BDividend YieldN/A31.29%5.11%4.22%P/E Ratio-85.4813.1022.4418.38Price / Sales11.99186.25390.71103.40Price / CashN/A57.5638.1834.62Price / Book23.624.676.704.22Net Income-$434.80M-$22.21M$3.22B$248.14M7 Day Performance1.27%0.35%2.23%2.49%1 Month Performance4.52%0.19%-0.93%1.01%1 Year Performance61.98%14.75%17.52%4.98% Natera Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NTRANatera2.8937 of 5 stars$150.93-2.6%$175.76+16.5%+64.7%$20.40B$1.70B-85.763,020Positive NewsGap DownFMSFresenius Medical Care3.7796 of 5 stars$24.99+2.2%$25.30+1.2%+20.6%$14.66B$19.34B20.65123,200Upcoming EarningsPositive NewsHIMSHims & Hers Health3.1754 of 5 stars$28.49+1.4%$38.08+33.7%+179.6%$6.34B$1.48B64.85650Upcoming EarningsAnalyst ForecastOptions VolumeNews CoverageGap DownGHGuardant Health3.9413 of 5 stars$47.79-1.1%$49.00+2.5%+172.3%$5.90B$739.02M-13.421,790Gap DownOPCHOption Care Health3.1485 of 5 stars$32.94+0.1%$33.75+2.5%+1.5%$5.41B$5.00B27.665,600Earnings ReportAnalyst UpgradeNews CoveragePositive NewsRDNTRadNet4.0186 of 5 stars$50.72+0.9%$69.75+37.5%+6.3%$3.75B$1.83B-722.548,970Positive NewsGap DownSHCSotera Health2.375 of 5 stars$11.25+0.8%$15.20+35.2%-0.6%$3.19B$1.10B44.983,000Upcoming EarningsWGSGeneDx2.2072 of 5 stars$113.51+2.3%$72.33-36.3%+963.4%$3.18B$305.45M-57.851,200News CoveragePositive NewsGap DownBTSGBrightSpring Health Services2.5411 of 5 stars$17.19+1.6%$21.67+26.1%+60.7%$3.01B$11.27B-66.0635,000Upcoming EarningsNews CoveragePositive NewsPRVAPrivia Health Group4.1118 of 5 stars$23.170.0%$27.14+17.2%+25.5%$2.81B$1.74B231.67810Analyst ForecastShort Interest ↓News CoveragePositive NewsCONConcentra Group Holdings ParentN/A$21.63+1.8%$28.50+31.8%N/A$2.74B$1.90B14.2511,000Upcoming EarningsPositive News Related Companies and Tools Related Companies FMS Competitors HIMS Competitors GH Competitors OPCH Competitors RDNT Competitors SHC Competitors WGS Competitors BTSG Competitors PRVA Competitors CON Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NTRA) was last updated on 4/30/2025 by MarketBeat.com Staff From Our PartnersTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredM.A.G.A. is Finished – This Could be even BetterYou’ve no doubt heard Trump’s rally cry: Make America Great Again. But recently the President made a big ch...Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredChina’s next move could destroy U.S. techThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Natera, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Natera With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy NTRA Stock Free NTRA Stock Alerts